Skip to main content
. 2022 Jun 30;32(7):877–884. doi: 10.4014/jmb.2206.06035

Fig. 3. Effects of SC28-7 administration on DSS-induced clinical symptoms of colitis in mice.

Fig. 3

(A) Disease activity index (DAI) is the average of the composite measures of weight loss, stool consistency and bleeding in stool after initiation of DSS treatment. In the graph, “a” represents the statistical significance (p < 0.05) of DSS and DSS+SC28-7 on the same day, and “b” means the significant difference (p < 0.05) between DSS and DSS+SB. (B) Area under curve (AUC) values of DAI for nine days after DSS treatment. (C) Changes in colon length. (D) Colon weight/length ratio in the DSS-colitis model. The data represent means ± S.E. (n = 8 mice/group). ### represents the significant difference between Cont and DSS group (p < 0.001). *p < 0.05, **p < 0.01, *** p < 0.001 vs. DSS.